<amendment session="106" chamber="h" number="975" updated="2013-07-17T08:15:43-04:00">
  <amends type="h" number="4461" sequence="36"/>
  <status datetime="2000-07-11">offered</status>
  <sponsor id="400050"/>
  <offered datetime="2000-07-11"/>
  <description>An amendment numbered 37 printed in the Congressional Record to add a provision to the bill that prohibits the use of funds from being used to approve any application for a new drug submitted by an entity that does not agree to a quarterly disclosure of the average price charged by the manufacturer for the most common dosage of the drug in each country that is a member of OECD.</description>
  <actions>
    <action datetime="2000-07-11T13:30:00-04:00">
      <text>Amendment (A036) offered by Mr. Brown (OH).</text>
      <reference ref="CR H5775-5777" label="consideration"/>
      <reference ref="CR H5775" label="text"/>
    </action>
    <action datetime="2000-07-11T13:39:00-04:00">
      <text>By unanimous consent, the Brown (OH) amendment was withdrawn.</text>
    </action>
  </actions>
</amendment>
